Applied DNA Sciences(us:APDN)

1.68

+1.20%

Updated on 2025-04-02

Open:1.67
Close:1.68
High:2.06
Low:1.63
Prev Close:1.66
Volume:4.20M
Turnover:7.85M
Turnover Ratio:381.60%
Shares:1.10M
MarketCap:1.85M
DateTotalTotal SharesTotal RatioNewIncreasedDecreased
2024-06-30358669078.42%10617
2024-03-31311452670.84%847
2023-12-31332236681.63%529
2023-09-3031262796019.24%567
2023-06-3033227353817.61%4213
2023-03-3130211185616.36%465
2022-12-3133200504515.53%5713
2022-09-3035182888514.17%121010
dateorgNametotalratiochangeShareschangeRatio
2024-03-31Armistice Capital, Llc648000.38%64800
2024-03-31Amh Equity Ltd270190.16%851946.05%
2024-03-31Goldman Sachs Group Inc121330.07%12133
2024-03-31Vanguard Group Inc87990.05%-17386-66.40%
2024-03-31Geode Capital Management, Llc69590.04%0
2024-03-31Blackrock Inc.50650.03%0
2024-03-31Silverberg Bernstein Capital Management Llc49150.03%0
2024-03-31State Street Corp37840.02%0
2024-03-31Hrt Financial Lp27260.02%2726
2024-03-31Raymond James & Associates24940.01%0

About

Applied DNA Sciences, Inc. engages in developing and marketing technologies to produce and detect deoxyribonucleic acid. It operates through the following segments: Therapeutic DNA Production, MDx Testing Services, and DNA Tagging and Security Products and Services. The Therapeutic DNA Production segment offers DNA detection via PCR to provide and develop clinical molecular diagnostics and genetic testing services. The MDx Testing Services segment is involved in performing and developing clinical molecular diagnostic tests and clinical laboratory testing services. The DNA Tagging and Security Products and Services segment includes manufacture and detection of DNA for industrial supply chain security services. The company was founded in 1983 and is headquartered in Stony Brook, NY.
Address:50 Health Sciences Drive

Market Movers